Biologically Based Methods for Cancer Risk Assessment: NATO Science Series A:, cartea 159
Editat de Curtis Travisen Limba Engleză Paperback – 30 apr 2013
Din seria NATO Science Series A:
- 15% Preț: 637.76 lei
- 15% Preț: 636.36 lei
- 15% Preț: 658.92 lei
- Preț: 386.07 lei
- 5% Preț: 367.12 lei
- Preț: 386.44 lei
- 18% Preț: 1197.00 lei
- 5% Preț: 710.68 lei
- Preț: 401.40 lei
- 15% Preț: 630.62 lei
- 5% Preț: 358.93 lei
- Preț: 395.97 lei
- 5% Preț: 2100.00 lei
- Preț: 395.79 lei
- Preț: 385.12 lei
- 15% Preț: 644.91 lei
- Preț: 376.34 lei
- Preț: 381.96 lei
- Preț: 387.01 lei
- Preț: 389.82 lei
- 15% Preț: 659.38 lei
- Preț: 383.85 lei
- 18% Preț: 925.07 lei
- 15% Preț: 635.70 lei
- Preț: 390.56 lei
- Preț: 389.82 lei
- 15% Preț: 636.51 lei
- Preț: 383.47 lei
- Preț: 373.55 lei
- 5% Preț: 384.34 lei
- 5% Preț: 1380.75 lei
- 15% Preț: 632.69 lei
- Preț: 388.70 lei
- Preț: 375.97 lei
- 5% Preț: 375.11 lei
- Preț: 392.43 lei
- 15% Preț: 632.87 lei
- Preț: 382.69 lei
- 5% Preț: 365.70 lei
- Preț: 388.88 lei
- 5% Preț: 377.77 lei
- Preț: 389.25 lei
- 5% Preț: 719.37 lei
- 18% Preț: 1189.98 lei
- 5% Preț: 375.46 lei
- Preț: 409.82 lei
Preț: 366.78 lei
Preț vechi: 386.07 lei
-5% Nou
Puncte Express: 550
Preț estimativ în valută:
70.20€ • 73.17$ • 58.44£
70.20€ • 73.17$ • 58.44£
Carte tipărită la comandă
Livrare economică 04-18 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781468456271
ISBN-10: 146845627X
Pagini: 368
Ilustrații: IX, 355 p. 54 illus.
Dimensiuni: 178 x 254 x 19 mm
Greutate: 0.64 kg
Ediția:Softcover reprint of the original 1st ed. 1989
Editura: Springer Us
Colecția Springer
Seria NATO Science Series A:
Locul publicării:New York, NY, United States
ISBN-10: 146845627X
Pagini: 368
Ilustrații: IX, 355 p. 54 illus.
Dimensiuni: 178 x 254 x 19 mm
Greutate: 0.64 kg
Ediția:Softcover reprint of the original 1st ed. 1989
Editura: Springer Us
Colecția Springer
Seria NATO Science Series A:
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
Research Needs for Biologically Based Risk Assessment.- Biological Bases for Cancer Models.- Multistage Models for Cancer Risk Assessment.- Understanding Multi-Stage Carcinogenesis at the Molecular Level: Notes on Recent Progress.- The Use of Enzyme-Altered Foci for Risk Assessment of Hepatocarcinogens.- Pathogenic Interrelationship of Focal Lesions, Nodules, Adenomas and Carcinomas in the Multistage Evolution of Azaserine-Induced Rat Pancreas Carcinogenesis.- Phenotypic Cellular Changes in Multistage Carcinogenesis.- Interspecies Extrapolation of Pharmacokinetics.- Interspecies Extrapolation.- Comparative Carcinogenesis: Is There a Theoretical Approach to Inter-Species Similarity.- Biological Basis for Interspecies Extrapolations of Halogenated Solvents and of 1,3-Butadiene.- Species-Specific Inhalation Pharmacokinetics of 2-Nitropropane, Methyl Ethyl Ketone, and n-Hexane.- Promotion as a Factor in Carcinogenesis.- Overview of Promotion as a Mechanism in Carcinogenesis.- Hepatocarcinogenesis by Non-Genotoxic Compounds.- The Role of Inhibited Intercellular Communication in Carcinogenesis: Implications for Risk Assessment From Exposure to Chemicals.- Comparative Analyses of the Timing and Magnitude of Genotoxic and Nongenotoxic Cellular Effects in Urinary Bladder Carcinogenesis.- Alterations in Gene Expression in Mouse Hepatocarcinogenesis.- Screening for Carcinogenesis.- Medium-Term Bioassay Models for Environmental Carcinogens — Two — Step Liver and Multi-Organ Carcinogenesis Protocols.- The Use of Aldh Induction as a Carcinogenic Risk Marker in Comparison With Typical in Vitro Mutagenicity System.- Expression of Inducible Cytochrome P-450 mRNAs During Promotion of Expermential Chemical Hepatocarcinogenesis.- An In Vitro Approach for Interspecies ExtrapolationUsing Animal and Human Airway Epithelial Cell Culture.- Cancer Risk Assessment.- Assement of Low-Exposure Risk from Carcinogens: Implications of the Knudson-Moolgavkar Two-Critical Mutation Theory.- A Biological Data Base for Methylene Chloride Risk Assessment.- Computer Simulation of Chemical Carcinogenesis.- Determination of Carcinogen Exposure by Immunological Techniques.- Risk Estimation for Leukemogenic Drugs.- Contributors.